|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||
| Investments, at fair value: | ||||||||||||||||
| Non-control/Non-affiliate investments | ||||||||||||||||
| Control investments | ||||||||||||||||
| Total investments, at fair value: | ||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||
| Foreign cash (cost of $113 and $70,445, respectively) | ||||||||||||||||
| Restricted cash (amounts related to a VIE $2,250 and $2,467, respectively) | ||||||||||||||||
| Interest receivable | ||||||||||||||||
| Right of use asset | ||||||||||||||||
| Other assets | ||||||||||||||||
| Total assets | ||||||||||||||||
| Liabilities | ||||||||||||||||
| Debt (net of unamortized debt issuance costs of $27,760 and $26,626, respectively; amounts related to a VIE $50,794 and $64,530, respectively) | ||||||||||||||||
| Accounts payable and accrued liabilities | ||||||||||||||||
| Operating lease liability | ||||||||||||||||
| Total liabilities | ||||||||||||||||
| Net assets consist of: | ||||||||||||||||
| Common stock, par value | ||||||||||||||||
| Capital in excess of par value | ||||||||||||||||
| Total distributable earnings | ||||||||||||||||
| Total net assets | ||||||||||||||||
| Total liabilities and net assets | ||||||||||||||||
| Shares of common stock outstanding ($0.001 par value and 300,000 authorized) (in shares) | ||||||||||||||||
| Net asset value per share (in dollars per share) | ||||||||||||||||
Loading...
